About: Traditional Chinese medicine for symptoms of upper respiratory tract of COVID-19: A protocol for systematic review and meta-analysis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Traditional Chinese medicine for symptoms of upper respiratory tract of COVID-19: A protocol for systematic review and meta-analysis Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Traditional Chinese medicine for symptoms of upper respiratory tract of COVID-19: A protocol for systematic review and meta-analysis
Creator	Zhou, Li Shi, Yu Tian, Li Dong, Lei Liang, Fangqi
source	Medline; PMC
abstract	BACKGROUND: Assessing the effectiveness and safety of traditional Chinese medicine (TCM) for symptoms of upper respiratory tract of coronavirus disease 2019 is the main purpose of this systematic review protocol. METHODS: The following electronic databases will be searched from inception to Sep 2020: the Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, EMBASE, Web of Science, TCM, China National Knowledge Infrastructure, Chinese Biomedical Literature Database, Chinese Scientific Journal Database (VIP database), and Wan-Fang Database. Search dates: from inception dates to June 2020. Language: English. Publication period: from inception dates to June 2020. The primary outcome is the time and rate of appearance of main symptoms (including coughing, pharyngalgia, and nasal obstruction). The secondary outcome is the length of hospital stay. Two independent reviewers will conduct the study selection, data extraction and assessment. RevMan V.5.3 will be used for the assessment of risk of bias and data synthesis. RESULTS: The results will provide a high-quality synthesis of current evidence for researchers in this subject area. CONCLUSION: The conclusion of our study will provide an evidence to judge whether TCM is effective and safe for the patients with symptoms of upper respiratory tract of coronavirus disease 2019. ETHICS AND DISSEMINATION: This protocol will not evaluate individual patient information or affect patient rights and therefore does not require ethical approval. Results from this review will be disseminated through peer-reviewed journals and conference reports. PROSPERO REGISTRATION NUMBER: CRD42020187422.
has issue date	2020-07-24(xsd:dateTime)
bibo:doi	10.1097/md.0000000000021320
bibo:pmid	32791725
has license	cc-by
sha1sum (hex)	a6be3c194f3bb4353c277deca3a7c24fb0029d28
schema:url	https://doi.org/10.1097/md.0000000000021320
resource representing a document's title	Traditional Chinese medicine for symptoms of upper respiratory tract of COVID-19: A protocol for systematic review and meta-analysis
has PubMed Central identifier	PMC7387049
has PubMed identifier	32791725
schema:publication	Medicine (Baltimore)
resource representing a document's body	covid:a6be3c194f3bb4353c277deca3a7c24fb0029d28#body_text
is schema:about of	named entity 'coronavirus disease 2019' named entity 'effectiveness' named entity 'symptoms' named entity 'traditional Chinese medicine' named entity 'coronavirus disease 2019' named entity 'TCM' named entity 'safety' named entity 'upper respiratory tract' named entity 'Cochrane' named entity 'Middle East respiratory syndrome' named entity 'publication bias' named entity 'coronavirus' named entity 'clinical practice' named entity 'Wiley Online Library' named entity 'statistical heterogeneity' named entity 'TCM' named entity 'Cochrane' named entity 'MERS-CoV' named entity 'FQL' named entity 'replication of viruses' named entity 'TCM' named entity 'Respiratory Infection' named entity 'Wuhan coronavirus' named entity 'fixed-effects' named entity 'nasal obstruction' named entity 'upper respiratory tract' named entity 'COVID-19 virus' named entity 'Respiratory Tract' named entity 'sample size' named entity 'adverse reactions' named entity 'COVID-19' named entity 'Wuhan' named entity 'virus' named entity 'Respiratory Infections' named entity 'cytokine' named entity 'complementary and alternative medicine' named entity 'SARS-CoV' named entity 'pneumonia' named entity 'Respiratory Tract' named entity 'sample size' named entity 'COVID' named entity 'inflammation' named entity 'coronavirus disease 2019' named entity '2019-nCoV' named entity 'SARS-CoV-2' named entity 'respiratory distress' named entity 'missing data' named entity 'Sensitivity analysis' named entity 'coughing' named entity 'sample size' named entity 'virus' named entity 'double-blind method' named entity 'randomized controlled trial' named entity 'coronavirus' named entity 'betacoronavirus' named entity 'systematic review' named entity 'Respiratory Tract Infections' named entity 'meta-analysis' named entity 'Coronavirus disease 2019' named entity 'COVID-19' named entity 'Subgroup analysis' named entity 'emerging disease' named entity 'Herbal Drugs' named entity 'Chinese medicine' named entity 'clinical trials' named entity 'Upper Respiratory' named entity 'sore throat' named entity 'ant' named entity 'COVID-19' named entity 'CoV' named entity 'clinical trial' named entity 'PROSPERO' named entity 'Systematic Reviews' named entity 'subgroup analysis' named entity 'statistical heterogeneity' named entity 'TCM' named entity 'COVID-19'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software